![Paul Chinn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Chinn is Chief Scientific Officer and Vice President of Research and Development for Aduro BioTech, Inc. Prior to joining Aduro BioTech, he worked for Biogen-IDEC Pharmaceuticals.
Previously, he was a Scientist of Synbiotics Corp.
Dr. Chinn has 20 years of experience in research and pre-clinical development of biotherapeutic proteins.
He received an undergraduate degree in Biochemistry from the University of California, Los Angeles and a PhD in Chemistry from the University of California, San Diego.
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | - |
Synbiotics LLC
 Synbiotics LLC Medical SpecialtiesHealth Technology Develops monoclonal antibody-based diagnostic and biological products | Chief Tech/Sci/R&D Officer | - |
| CHINOOK THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
Synbiotics LLC
Synbiotics LLC Medical SpecialtiesHealth Technology Develops monoclonal antibody-based diagnostic and biological products | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms for cancer | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
